BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21264910)

  • 1. Pre-eminence and persistence of immature natural killer cells in acute myeloid leukemia patients in first complete remission.
    Dauguet N; Récher C; Demur C; Fournié JJ; Poupot M; Poupot R
    Am J Hematol; 2011 Feb; 86(2):209-13. PubMed ID: 21264910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cell receptor--repertoire and functions after induction therapy by polyclonal rabbit anti-thymocyte globulin in unsensitized kidney transplant recipients.
    Hadaya K; Avila Y; Valloton L; de Rham C; Bandelier C; Ferrari-Lacraz S; Pascual M; Pantaleo G; Martin PY; Buhler L; Villard J
    Clin Immunol; 2010 Nov; 137(2):250-60. PubMed ID: 20719569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and emerging therapies for acute myeloid leukemia.
    Robak T; Wierzbowska A
    Clin Ther; 2009; 31 Pt 2():2349-70. PubMed ID: 20110045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer receptors distribution in multiple sclerosis: Relation to clinical course and interferon-beta therapy.
    Martínez-Rodríguez JE; Saez-Borderías A; Munteis E; Romo N; Roquer J; López-Botet M
    Clin Immunol; 2010 Oct; 137(1):41-50. PubMed ID: 20580616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of CD158 and NKG2A Inhibitory Receptors and Underexpression of NKG2D and NKp46 Activating Receptors on NK Cells in Acute Myeloid Leukemia.
    Sandoval-Borrego D; Moreno-Lafont MC; Vazquez-Sanchez EA; Gutierrez-Hoya A; López-Santiago R; Montiel-Cervantes LA; Ramírez-Saldaña M; Vela-Ojeda J
    Arch Med Res; 2016 Jan; 47(1):55-64. PubMed ID: 26876298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered phenotype of natural killer cell subsets after haploidentical stem cell transplantation.
    Schulze A; Schirutschke H; Oelschlägel U; Schmitz M; Füssel M; Wassmuth R; Ehninger G; Bornhäuser M; Platzbecker U
    Exp Hematol; 2008 Apr; 36(4):378-89. PubMed ID: 18261840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased number of CD16(+)CD56(dim) NK cells in peripheral blood mononuclear cells after allogeneic cord blood transplantation.
    Tanaka J; Sugita J; Asanuma S; Arita K; Shono Y; Kikutchi M; Shiratori S; Wakasa K; Yasumoto A; Shigematu A; Kondo T; Kobayashi T; Asaka M; Imamura M
    Hum Immunol; 2009 Sep; 70(9):701-5. PubMed ID: 19524005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expansion of natural killer cells with lytic activity against autologous blasts from adult and pediatric acute lymphoid leukemia patients in complete hematologic remission.
    Torelli GF; Guarini A; Maggio R; Alfieri C; Vitale A; Foà R
    Haematologica; 2005 Jun; 90(6):785-92. PubMed ID: 15951291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-E upregulation on IFN-gamma-activated AML blasts impairs CD94/NKG2A-dependent NK cytolysis after haplo-mismatched hematopoietic SCT.
    Nguyen S; Beziat V; Dhedin N; Kuentz M; Vernant JP; Debre P; Vieillard V
    Bone Marrow Transplant; 2009 May; 43(9):693-9. PubMed ID: 19011664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cell receptor repertoire is comparable amongst newly diagnosed acute myeloid leukemia of different French-American-British subtypes, risk categories and chemosensitivities.
    Ho X; Fook-Chong S; Linn YC
    Leuk Lymphoma; 2014 Feb; 55(2):342-8. PubMed ID: 23550989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early evaluation of natural killer activity in post-transplant acute myeloid leukemia patients.
    Pittari G; Fregni G; Roguet L; Garcia A; Vataire AL; Wittnebel S; Amsellem S; Chouaib S; Bourhis JH; Caignard A
    Bone Marrow Transplant; 2010 May; 45(5):862-71. PubMed ID: 19802033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia.
    Stringaris K; Sekine T; Khoder A; Alsuliman A; Razzaghi B; Sargeant R; Pavlu J; Brisley G; de Lavallade H; Sarvaria A; Marin D; Mielke S; Apperley JF; Shpall EJ; Barrett AJ; Rezvani K
    Haematologica; 2014 May; 99(5):836-47. PubMed ID: 24488563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomere length in human natural killer cell subsets.
    Ouyang Q; Baerlocher G; Vulto I; Lansdorp PM
    Ann N Y Acad Sci; 2007 Jun; 1106():240-52. PubMed ID: 17303822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of NK cell activating receptors following allogeneic hematopoietic stem cell transplantation under a lymphodepleting reduced intensity regimen is associated with elevated IL-15 levels.
    Boyiadzis M; Memon S; Carson J; Allen K; Szczepanski MJ; Vance BA; Dean R; Bishop MR; Gress RE; Hakim FT
    Biol Blood Marrow Transplant; 2008 Mar; 14(3):290-300. PubMed ID: 18275895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cell activation in the lung allograft early posttransplantation.
    Meehan AC; Sullivan LC; Mifsud NA; Brooks AG; Snell GI; Kotsimbos TC; Westall GP
    Transplantation; 2010 Mar; 89(6):756-63. PubMed ID: 20019647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconstitution of natural killer cell receptor repertoires after unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation: analyses of CD94:NKG2A and killer immunoglobulin-like receptor expression and their associations with clinical outcome.
    Zhao XY; Huang XJ; Liu KY; Xu LP; Liu DH
    Biol Blood Marrow Transplant; 2007 Jun; 13(6):734-44. PubMed ID: 17531784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment.
    Gonzalez VD; Falconer K; Björkström NK; Blom KG; Weiland O; Ljunggren HG; Alaeus A; Sandberg JK
    J Immunol; 2009 Nov; 183(10):6612-8. PubMed ID: 19846870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of autologous transplantation of peripheral blood progenitor cells as postremission management of patients > or =60 years with acute myelogenous leukemia.
    Lashkari A; Lowe T; Collisson E; Paquette R; Emmanouilides C; Territo M; Schiller G
    Biol Blood Marrow Transplant; 2006 Apr; 12(4):466-71. PubMed ID: 16545730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of human natural killer cell receptors in early life.
    Sundström Y; Nilsson C; Lilja G; Kärre K; Troye-Blomberg M; Berg L
    Scand J Immunol; 2007; 66(2-3):335-44. PubMed ID: 17635811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expansion of NKG2A-LIR1- natural killer cells in HLA-matched, killer cell immunoglobulin-like receptors/HLA-ligand mismatched patients following hematopoietic cell transplantation.
    Rathmann S; Glatzel S; Schönberg K; Uhrberg M; Follo M; Schulz-Huotari C; Kaymer M; Veelken H; Finke J; Fisch P
    Biol Blood Marrow Transplant; 2010 Apr; 16(4):469-81. PubMed ID: 20044012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.